Cross‐Country Measures for Monitoring Epilepsy Care

Summary:  Purpose: The International League Against Epilepsy (ILAE) Commission on Healthcare Policy in consultation with the World Health Organization (WHO) examined the applicability and usefulness of various measures for monitoring epilepsy healthcare services and systems across countries. The goal is to provide planners and policymakers with tools to analyze the impact of healthcare services and systems and evaluate efforts to improve performance.

[1]  M. Sperling,et al.  Validity and Responsiveness of Generic Preference-based HRQOL Instruments in Chronic Epilepsy , 2006, Quality of Life Research.

[2]  D. Chisholm.  Cost‐effectiveness of First‐line Antiepileptic Drug Treatments in the Developing World: A Population‐level Analysis , 2005, Epilepsia.

[3]  C. Mandlhate,et al.  Prevalence of epilepsy its treatment gap and knowledge, attitude and practice of its population in sub-urban Senegal an ILAE/IBE/WHO study , 2005, Seizure.

[4]  M. Druet‐Cabanac,et al.  Epidemiology and aetiology of epilepsy in sub-Saharan Africa , 2005, The Lancet Neurology.

[5]  Samuel Wiebe,et al.  National and Regional Prevalence of Self‐reported Epilepsy in Canada , 2004, Epilepsia.

[6]  L. Kapiriri,et al.  Can the value choices in DALYs influence global priority-setting? , 2004, Health policy.

[7]  M. Druet‐Cabanac,et al.  Economic Evaluation of Epilepsy in Kiremba (Burundi): A Case–Control Study , 2004, Epilepsia.

[8]  E. Beghi,et al.  Direct Cost of Medical Management of Epilepsy among Adults in Italy: A Prospective Cost‐of‐Illness Study (EPICOS) , 2004, Epilepsia.

[9]  Pascale Allotey,et al.  The DALY, context and the determinants of the severity of disease: an exploratory comparison of paraplegia in Australia and Cameroon. , 2003, Social science & medicine.

[10]  Shih-Yi Lin,et al.  Leptin in Relation to Hepatocellular Carcinoma in Patients with Liver Cirrhosis , 2003, Hormone Research in Paediatrics.

[11]  R. Krecek,et al.  The current status of neurocysticercosis in Eastern and Southern Africa. , 2003, Acta tropica.

[12]  S. Siziya,et al.  The emergence of Taenia solium cysticercosis in Eastern and Southern Africa as a serious agricultural problem and public health risk. , 2003, Acta tropica.

[13]  Josemir W Sander,et al.  The prevalence and treatment gap in epilepsy in China , 2003, Neurology.

[14]  R. Flink,et al.  The Provision of Epilepsy Care across Europe , 2003 .

[15]  Josemir W Sander.  The epidemiology of epilepsy revisited , 2003, Current opinion in neurology.

[16]  M. Eliasziw,et al.  Clinically important change in quality of life in epilepsy , 2002, Journal of neurology, neurosurgery, and psychiatry.

[17]  M. Leonardi,et al.  The Global Burden of Epilepsy , 2002, Epilepsia.

[18]  R. Kale.  The Treatment Gap , 2002 .

[19]  Lior Pachter,et al.  The computational challenges of applying comparative-based computational methods to whole genomes , 2002, Briefings Bioinform..

[20]  C. Begley,et al.  Early treatment cost in epilepsy and how it varies with seizure type and frequency , 2001, Epilepsy Research.

[21]  A. Berg.  Mortality Risk N Children with Epilepsy: The Dutch Study of Epilepsy in Childhood , 2001, Epilepsy currents.

[22]  M. Brodie,et al.  Effectiveness of First Antiepileptic Drug , 2001, Epilepsia.

[23]  C. Murray,et al.  World Health Report 2000: a step towards evidence-based health policy , 2001, The Lancet.

[24]  K. Stavem,et al.  Properties of the 15D and EQ-5D utility measures in a community sample of people with epilepsy , 2001, Epilepsy Research.

[25]  H. Meinardi,et al.  The Treatment Gap in Epilepsy: The Current Situation and Ways Forward , 2001, Epilepsia.

[26]  Josemir W Sander,et al.  NHS services for epilepsy from the patient’s perspective: a survey of primary, secondary and tertiary care access throughout the UK , 2000, Seizure.

[27]  A. Preti,et al.  Death by Homicide in Italy, 1980–94: Age and Gender Differences among Victims , 2000, Medicine, science, and the law.

[28]  Josemir W Sander,et al.  The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. , 2000, Brain : a journal of neurology.

[29]  P. Jallon,et al.  The contributing factors to medical cost of epilepsy: an estimation based on a French prospective cohort study of patients with newly diagnosed epileptic seizures (the CAROLE study) , 2000, Seizure.

[30]  G. Riordan,et al.  Childhood Secondary (Symptomatic) Epilepsy, Seizure Control, and Intellectual Handicap in a Nontropical Region of South Africa , 1999, Epilepsia.

[31]  L A Fingerhut,et al.  International comparative analysis of injury mortality. Findings from the ICE on injury statistics. International Collaborative Effort on Injury Statistics. , 1998, Advance data.

[32]  G. Baker,et al.  Uptake and Costs of Care for Epilepsy: Findings from a U.K. Regional Study , 1998, Epilepsia.

[33]  G. Zaccara,et al.  Adjunctive lamotrigine therapy in patients with refractory seizures: a lifetime cost–utility analysis , 1998, European Journal of Clinical Pharmacology.

[34]  J. Barendregt,et al.  Global burden of disease , 1997, The Lancet.

[35]  S. Benatar.  Health care reform in the new South Africa. , 1997, The New England journal of medicine.

[36]  S Shinnar,et al.  THE EPIDEMIOLOGY OF EPILEPSY: Past, Present, and Future , 1996 .

[37]  A. J. Thomson.  Neurocysticercosis--experience at the teaching hospitals of the University of Cape Town. , 1993, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[38]  S. Shorvon,et al.  Epilepsy in Developing Countries: A Review of Epidemiological, Sociocultural, and Treatment Aspects , 1988, Epilepsia.

[39]  W. Hauser,et al.  The Epidemiology of Epilepsy in Rochester, Minnesota, 1935 Through 1967 , 1975, Epilepsia.

[40]  R. Flink,et al.  ILAE Commission of European Affairs Subcommission on European Guidelines 1998-2001: The provision of epilepsy care across Europe. , 2003, Epilepsia.

[41]  Christopher J L Murray,et al.  Health systems performance assessment: debates, methods and empiricism. , 2003 .

[42]  Alan D. Lopez,et al.  Summary Measures of Population Health: Concepts, Ethics, Measurement and Applications , 2002 .

[43]  P. Jallon,et al.  Clinical Research : Newly Diagnosed Unprovoked Epileptic Seizures : Presentation at Diagnosis in CAROLE Study , 2001 .

[44]  G. Mcnicoll.  UNITED NATIONS DEPARTMENT OF ECONOMIC AND SOCIAL AFFAIRS , 1999 .